XML 93 R77.htm IDEA: XBRL DOCUMENT v3.6.0.2
Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenues (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues $ 109,871 $ 87,821 $ 45,212
ZIOPHARM Oncology, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 33,836 19,306 14,621
Oragenics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,752 6,535 1,643
Fibrocell Science, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 5,942 12,179 6,192
Genopaver, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 6,117 3,829 1,783
S & I Ophthalmic, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 6,141 4,115 2,832
OvaXon, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,934 2,540 2,799
Intrexon Energy Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 17,552 13,447 6,102
Persea Bio, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,278 1,241  
Ares Trading S.A.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 10,192 4,728  
Thrive Agrobiotics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,714 266  
Intrexon Energy Partners II, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 3,169 167  
Exotech Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 792    
Relieve Genetics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,239    
Intrexon T1D Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,908    
AD Skincare, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 695    
Genten Therapeutics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 386    
CRS Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 148    
Other      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 13,076 19,468 9,240
Upfront and Milestone Payments      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 34,433 32,513 9,625
Upfront and Milestone Payments | ZIOPHARM Oncology, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 11,529 2,855 2,577
Upfront and Milestone Payments | Oragenics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,047 5,679 1,045
Upfront and Milestone Payments | Fibrocell Science, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,419 6,046 1,794
Upfront and Milestone Payments | Genopaver, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 273 273 273
Upfront and Milestone Payments | S & I Ophthalmic, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 0 0 0
Upfront and Milestone Payments | OvaXon, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 0 0 0
Upfront and Milestone Payments | Intrexon Energy Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,500 2,500 1,875
Upfront and Milestone Payments | Persea Bio, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 500 500  
Upfront and Milestone Payments | Ares Trading S.A.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 6,389 3,933  
Upfront and Milestone Payments | Thrive Agrobiotics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 185 46  
Upfront and Milestone Payments | Intrexon Energy Partners II, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,000 167  
Upfront and Milestone Payments | Exotech Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 417    
Upfront and Milestone Payments | Relieve Genetics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 361    
Upfront and Milestone Payments | Intrexon T1D Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 821    
Upfront and Milestone Payments | AD Skincare, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 241    
Upfront and Milestone Payments | Genten Therapeutics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 122    
Upfront and Milestone Payments | CRS Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 57    
Upfront and Milestone Payments | Other      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 5,572 10,514 2,061
Research and Development Services      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 75,438 55,308 35,587
Research and Development Services | ZIOPHARM Oncology, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 22,307 16,451 12,044
Research and Development Services | Oragenics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,705 856 598
Research and Development Services | Fibrocell Science, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 3,523 6,133 4,398
Research and Development Services | Genopaver, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 5,844 3,556 1,510
Research and Development Services | S & I Ophthalmic, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 6,141 4,115 2,832
Research and Development Services | OvaXon, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 2,934 2,540 2,799
Research and Development Services | Intrexon Energy Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 15,052 10,947 4,227
Research and Development Services | Persea Bio, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 778 741  
Research and Development Services | Ares Trading S.A.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 3,803 795  
Research and Development Services | Thrive Agrobiotics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,529 220  
Research and Development Services | Intrexon Energy Partners II, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,169 0  
Research and Development Services | Exotech Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 375    
Research and Development Services | Relieve Genetics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 878    
Research and Development Services | Intrexon T1D Partners, LLC      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 1,087    
Research and Development Services | AD Skincare, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 454    
Research and Development Services | Genten Therapeutics, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 264    
Research and Development Services | CRS Bio, Inc.      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues 91    
Research and Development Services | Other      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Collaboration and licensing revenues $ 7,504 $ 8,954 $ 7,179